Douglas Greene, MD

« BACK
Douglas Greene, MD – Executive Vice President Research and Development
“Only by listening to clinicians, understanding their needs, and observing their challenges firsthand can we fully respond to the complexities of critical care. Our development of therapies is constantly refined by our presence in, commitment to, and passion for this complex arena. Together, we will advance critical care to the next level.”

Douglas Greene, MD, has served as our Executive Vice President, Research and Development since June 2010. Prior to joining us, from April 2009 to April 2010, Dr. Greene served as Senior Vice President and Senior Scientific Advisor at Sanofi-aventis, a global pharmaceutical company. From August 2006 to March 2009, Dr. Greene served as Senior Vice President and Chief Medical Officer of the US business at Sanofi-aventis. From June 2003 to July 2006, Dr. Greene served as Vice President and Head of Corporate Regulatory Development at Sanofi-aventis. Dr. Greene was Executive Vice President of Clinical Sciences and Product Development at Merck Research Laboratories and Corporate Officer of Merck, Inc., a global pharmaceutical company, from May 2000 to January 2003. Dr. Greene also was a member of the US Food and Drug Administration’s Endocrinologic and Metabolic Drug Advisory Committee from 1988 to 1994, and acted as Chairman of the Advisory Committee from 1990 to 1994. Dr. Greene holds an MD from the Johns Hopkins School of Medicine.